Which has the lower trailing P/E, CI or REGN?

CI has the lower trailing P/E: CI trades at 11.62 and REGN at 19.33. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or REGN?

Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus REGN at 4.64%.

Does CI or REGN pay a bigger dividend?

CI yields 2.20% and REGN yields 0.46% based on trailing dividends and the latest price.

Is CI or REGN more profitable?

REGN runs the higher net margin — CI at 2.27% versus REGN at 27.86%.

How have CI and REGN total returns compared?

Over the past 10 years, CI delivered 9.30% and REGN delivered 7.81% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Regeneron Pharmaceuticals, Inc. (REGN)

A side-by-side comparison of Cigna Corporation and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$74.19B

$280.76HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

REGN

Regeneron Pharmaceuticals, Inc.

$80.51B

$781.49HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — CI vs REGN

growth of $100 · dividends reinvested · last 10y

CI +140.4% (+9.2%/yr)REGN +108.5% (+7.6%/yr)CI compounded faster over this window

CI REGN

CI vs REGN: by the numbers

•REGN is the larger company ($80.51B vs $74.19B market cap).
•CI trades at the lower trailing earnings multiple (11.62 vs 19.33 P/E), one valuation lens rather than an overall verdict.
•REGN converts more revenue to profit (27.86% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 4.64% CAGR).
•CI pays the higher dividend yield (2.20% vs 0.46%).

Metrics side by side

Valuation

Metric	CI	REGN
P/E ratio	11.62	19.33
Forward P/E	9.20	14.40
P/S ratio	0.26	5.18
P/B ratio	1.74	2.54
EV / EBITDA	8.08	17.79
FCF yield	12.28%	4.37%

Profitability

Metric	CI	REGN
Gross margin	11.66%	84.86%
Operating margin	3.46%	25.56%
Net margin	2.27%	27.86%
ROE	15.05%	13.65%
ROIC	7.69%	9.19%

Dividends

Metric	CI	REGN
Dividend yield	2.20%	0.46%
Payout ratio	25.62%	9.15%

Growth (annualized)

Metric	CI	REGN
Revenue CAGR (5Y)	11.11%	4.64%
EPS CAGR (5Y)	-0.76%	5.70%
FCF CAGR (5Y)	-1.95%	15.77%
Total return CAGR (5Y)	8.53%	4.76%

Frequently asked

Which has the lower trailing P/E, CI or REGN?: CI has the lower trailing P/E: CI trades at 11.62 and REGN at 19.33. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or REGN?: Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus REGN at 4.64%.
Does CI or REGN pay a bigger dividend?: CI yields 2.20% and REGN yields 0.46% based on trailing dividends and the latest price.
Is CI or REGN more profitable?: REGN runs the higher net margin — CI at 2.27% versus REGN at 27.86%.
How have CI and REGN total returns compared?: Over the past 10 years, CI delivered 9.30% and REGN delivered 7.81% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Regeneron Pharmaceuticals P/E ratio Cigna dividend yield Regeneron Pharmaceuticals dividend yield Cigna ROE Regeneron Pharmaceuticals ROE Cigna operating margin Regeneron Pharmaceuticals operating margin Cigna revenue growth Regeneron Pharmaceuticals revenue growth Cigna free cash flow Regeneron Pharmaceuticals free cash flow

Cigna & Regeneron Pharmaceuticals appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.